1-3 of 3
Anthonie WA. Lensing, MD PhD
Close
Sort by
Journal Articles

Rivaroxaban for Treatment of Pediatric Venous Thromboembolism. an Einstein-Jr Phase 3 Dose-Exposure-Response Evaluation

Guy Young, MD, Anthonie WA. Lensing, MD PhD, Paul Monagle, MBBS, MSc, Christoph Male, MD, Dagmar Kubitza, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 164.
https://doi.org/10.1182/blood-2019-124873
Published: 2019
Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Faizan Khan, BSc, Alvi Rahman, MSc, Marc Carrier, MD MSc, Clive Kearon, MB, PhD, Jeffrey I. Weitz, MD, Sam Schulman, MD PhD FRCPC, Francis Couturaud, MD PhD, Sabine Eichinger, MD, Paul Alexander Kyrle, MD, Cecilia Becattini, MD PhD, Giancarlo Agnelli, MD, Timothy Brighton, MD, Anthonie WA. Lensing, MD PhD, Martin H. Prins, MD PhD, Elham Sabri, MSc, Brian Hutton, PhD, Laurent Pinede, MD PhD, Mary Cushman, MD MSc, Gualtiero Palareti, MD, George Wells, PhD, Paolo Prandoni, MD PhD, Harry R. Büller, MD PhD, Marc A. Rodger, MD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 2527.
https://doi.org/10.1182/blood-2018-99-113589
Published: 2018
Journal Articles

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Bruce L. Davidson, MD MPH, Philip S. Wells, MD FRCPC, MSc, Martin H. Prins, MD PhD, Jan Beyer-Westendorf, MD, Anthonie WA. Lensing, MD PhD, Lloyd Haskell, MD, Bennett Levitan, MD PhD, François Laliberté, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, MA, Qi Zhao, MPH, Zhong Yuan, MD PhD, Jeff Schein, Paolo Prandoni, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 218.
https://doi.org/10.1182/blood.V130.Suppl_1.218.218
Published: 2017